Trials / Sponsors / Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum Malaria | Phase 2 | 2024-04-26 |
| Completed | Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19 COVID-19 | Phase 3 | 2024-01-19 |
| Withdrawn | Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19 COVID-19 | Phase 3 | 2023-05-30 |
| Completed | To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19 Post-COVID-19 | Phase 3 | 2023-03-23 |
| Withdrawn | Clinical Study of Meplazumab to Treat With Malaria Malaria (Plasmodium Falciparum) | Phase 1 | 2023-03-01 |
| Completed | the Safety and Efficacy of Meplazumab in Patients With COVID-19 Covid19 | Phase 2 / Phase 3 | 2022-01-21 |
| Completed | Study to Assess the Effect of Meplazumab on COVID-19 COVID-19 | Phase 2 / Phase 3 | 2021-02-15 |